The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PERSEPHONE: 6 versus 12 months (m) of adjuvant trastuzumab in patients (pts) with HER2 positive (+) early breast cancer (EBC): Randomised phase 3 non-inferiority trial with definitive 4-year (yr) disease-free survival (DFS) results.
Helena Margaret Earl
Honoraria - Amgen; AstraZeneca; Daiichi Sankyo; Pfizer
Consulting or Advisory Role - AstraZeneca; Celgene; Pfizer; Roche
Research Funding - Roche; Sanofi
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Daiichi Sankyo; Pfizer
Louise Hiller
No Relationships to Disclose
Anne-Laure Vallier
No Relationships to Disclose
Shrushma Loi
No Relationships to Disclose
Donna Howe
No Relationships to Disclose
Helen B Higgins
No Relationships to Disclose
Karen McAdam
Honoraria - Novartis; Roche
Consulting or Advisory Role - Roche
Luke Hughes-Davies
No Relationships to Disclose
Adrian Nigel Harnett
Speakers' Bureau - Genomic Health
Mei-Lin Ah-See
Honoraria - Roche
Consulting or Advisory Role - AstraZeneca (I); Merck Sharp & Dohme (I); Novartis (I); Pierre Fabre (I)
Richard Simcock
Consulting or Advisory Role - Genomic Health; Novartis
Daniel William Rea
Honoraria - Novartis; Pfizer; Roche
Consulting or Advisory Role - Novartis; Roche
Research Funding - AstraZeneca (Inst); PUMA NALA (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Roche
Janine Mansi
No Relationships to Disclose
Jean Abraham
Research Funding - AstraZeneca/MedImmune
Carlos Caldas
Consulting or Advisory Role - AstraZeneca/MedImmune
Research Funding - AstraZeneca (Inst); Genentech/Roche (Inst); SERVIER (Inst)
Claire Hulme
No Relationships to Disclose
David Miles
Honoraria - Roche/Genentech
Consulting or Advisory Role - Roche/Genentech
Travel, Accommodations, Expenses - Roche/Genentech
Andrew M. Wardley
Honoraria - AstraZeneca; Lilly; Novartis; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Lilly; MSD Oncology; Novartis; Pierre Fabre; Roche
Speakers' Bureau - AstraZeneca; Eisai; Novartis; Roche
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - Amgen; Roche
David A. Cameron
Research Funding - AstraZeneca (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Novartis
Janet Dunn
No Relationships to Disclose